HIV reverse transcriptase activity assay: A feasible surrogate for HIV viral load measurement in China

Diagnostic Microbiology and Infectious Disease

Volumn 68, Issue 3, 2010, Pages 208-213

  Huang, Dedong ^a   Zhuang, Yan ^a   Zhai, Song ^a   Song, Yang ^a   Liu, Qingquan ^a   Zhao, Shuguang ^a   Wang, Shaoyang ^a   Li, Xinhong ^a   Kang, Wenzhen ^a   Greengrass, Vicki ^b   Plate, Megan ^b   Crowe, Suzanne M ^b   Sun, Yongtao ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

Author keywords

AIDS; HIV; HIV diagnosis test; HIV viral load; Reverse transcriptase activity; Treatment monitoring

Indexed keywords

DIDANOSINE; EFAVIRENZ; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE; STAVUDINE; VIRUS RNA; ZIDOVUDINE;

ARTICLE; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CHINA; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENZYME ACTIVITY; ENZYME ASSAY; FEASIBILITY STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; VIRUS LOAD;

ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CHINA; HIV; HIV INFECTIONS; HIV REVERSE TRANSCRIPTASE; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; STATISTICS AS TOPIC; VIRAL LOAD;

EID: 77957888625     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.06.007     Document Type: Article

References (25)

1. Braun J., Plantier J.C., Hellot M.F., Tuaillon E., Gueudin M., Damond F., Malmsten A., Corrigan G.E., Simon F. A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypes. AIDS 2003, 17:331-336.
2. Constantine N.T., Zink H. HIV testing technologies after two decades of evolution. Indian J. Med. Res. 2005, 121:519-538.
3. Crowe S., Turnbull S., Oelrichs R., Dunne A. Monitoring of human immunodeficiency virus infection in resource-constrained countries. Clin. Infect. Dis. 2003, 37(Suppl. 1):S25-35.
4. Damond F., Avettand-Fenoel V., Collin G., Roquebert B., Plantier J.C., Ganon A., Sizmann D., Babiel R., Glaubitz J., Chaix M.L., Brun-Vezinet F., Descamps D., Rouzioux C. Evaluation of an upgraded version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test for HIV-1 load quantification. J. Clin. Microbiol. 2010, 48:1413-1416.
5. Damond F., Roquebert B., Benard A., Collin G., Miceli M., Yeni P., Brun-Vezinet F., Descamps D. Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays. J. Clin. Microbiol. 2007, 45:3436-3438.
6. Deng W., Fu P., Bao L., Vidal N., He Q., Qin C., Peeters M., Delaporte E., Andrieu J.M., Lu W. Molecular epidemiological tracing of HIV-1 outbreaks in Hainan island of southern China. AIDS 2009, 23:977-985.
7. Deng X., Liu H., Shao Y., Rayner S., Yang R. The epidemic origin and molecular properties of B': a founder strain of the HIV-1 transmission in Asia. AIDS 2008, 22:1851-1858.
8. Fiscus S.A., Cheng B., Crowe S.M., Demeter L., Jennings C., Miller V., Respess R., Stevens W. HIV-1 viral load assays for resource-limited settings. PLoS Med. 2006, 3:e417.
9. Greengrass V., Lohman B., Morris L., Plate M., Steele P.M., Walson J.L., Crowe S.M. Assessment of the low-cost Cavidi ExaVir Load assay for monitoring HIV viral load in pediatric and adult patients. J. Acquir. Immune Defic. Syndr. 2009, 52:387-390.
10. Greengrass V.L., Plate M.M., Steele P.M., Denholm J.T., Cherry C.L., Morris L.M., Hearps A., Crowe S.M. Evaluation of the Cavidi ExaVir Load assay (version 3) for plasma human immunodeficiency virus type 1 load monitoring. J. Clin. Microbiol. 2009, 47:3011-3013.
11. Greengrass V.L., Turnbull S.P., Hocking J., Dunne A.L., Tachedjian G., Corrigan G.E., Crowe S.M. Evaluation of a low cost reverse transcriptase assay for plasma HIV-1 viral load monitoring. Curr. HIV Res. 2005, 3:183-190.
12. Gueudin M., Plantier J.C., Lemee V., Schmitt M.P., Chartier L., Bourlet T., Ruffault A., Damond F., Vray M., Simon F. Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes. J. Acquir. Immune Defic. Syndr. 2007, 44:500-505.
13. Jennings C., Fiscus S.A., Crowe S.M., Danilovic A.D., Morack R.J., Scianna S., Cachafeiro A., Brambilla D.J., Schupbach J., Stevens W., Respess R., Varnier O.E., Corrigan G.E., Gronowitz J.S., Ussery M.A., Bremer J.W. Comparison of two human immunodeficiency virus (HIV) RNA surrogate assays to the standard HIV RNA assay. J. Clin. Microbiol. 2005, 43:5950-5956.
14. Malmsten A., Shao X.W., Aperia K., Corrigan G.E., Sandstrom E., Kallander C.F., Leitner T., Gronowitz J.S. HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma. J. Med. Virol. 2003, 71:347-359.
15. Malmsten A., Shao X.W., Sjodahl S., Fredriksson E.L., Pettersson I., Leitner T., Kallander C.F., Sandstrom E., Gronowitz J.S. Improved HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma. J. Med. Virol. 2005, 76:291-296.
16. Mine M., Bedi K., Maruta T., Madziva D., Tau M., Zana T., Gaolathe T., Moyo S., Seipone K., Ndwapi N., Essex M., Marlink R. Quantitation of human immunodeficiency virus type 1 viral load in plasma using reverse transcriptase activity assay at a district hospital laboratory in Botswana: a decentralization pilot study. J. Virol. Methods 2009, 159:93-97.
17. Pas S., Rossen J.W., Schoener D., Thamke D., Pettersson A., Babiel R., Schutten M. Performance evaluation of the new Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 for quantification of human immunodeficiency virus type 1 RNA. J. Clin. Microbiol. 2010, 48:1195-1200.
18. Rouet F., Rouzioux C. HIV-1 viral load testing cost in developing countries: what's new?. Expert. Rev. Mol. Diagn. 2007, 7:703-707.
19. Rouet F., Rouzioux C. The measurement of HIV-1 viral load in resource-limited settings: how and where?. Clin. Lab. 2007, 53:135-148.
20. van Rooijen L.B., Greengrass V., Morris L.M., Plate M.M., Gouillou M., Tachedjian G., Sluis-Cremer N., Hearps A.C., Crowe S.M. Effect of reverse transcriptase inhibitors and mutations on the low-cost Cavidi reverse transcriptase viral load assay. J. Acquir. Immune. Defic. Syndr. 2009, 52:527-529.
21. Wang S., Zhuang Y., Zhai S., Zhao S., Kang W., Li X., Yu X.G., Walker B.D., Altfeld M.A., Sun Y. Association between HIV type 1-specific T cell responses and CD4+ T cell counts or CD4+:CD8+ T cell ratios in HIV type 1 subtype B infection in China. AIDS Res. Hum. Retroviruses 2006, 22:780-787.
22. Yin W.Y., Zhang F.J., Juniper N., Wu Z.Y. Improving China's antiretroviral treatment program: assessing current and future performance using the principals of ethics. Chin. Med. J. (Engl.) 2009, 122:1346-1351.
23. Zhang F, Dou Z, Ma Y, Zhao Y, Liu Z, Bulterys M, Chen RY (2009) Five-year outcomes of the China National Free Antiretroviral Treatment Program. Ann Intern Med 151: 241-251, W-252.
24. Zhao F., Wang Z., Li W.J. Human immunodeficiency virus type 1 subtypes prevalence in central China. Yonsei Med. J. 2009, 50:644-649.
25. Zhou X.L., He X., Hong K.X., Wang Z., Xing A.H., Ruan Y.H., Chen J.P., Xing H., Shao Y.M. Genetic variation of gag gene in HIV-1 subtype B infections from Henan and Shanxi provinces of China. Bing Du Xue Bao 2009, 25:95-100.